Big Pharma Split Corp.

PRM.TO · TSX
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets––––
Cash & EquivalentsCA$1,031CA$204CA$819CA$1,430
Short-Term InvestmentsCA$25,175CA$0CA$0CA$0
ReceivablesCA$97CA$77CA$14,004CA$103
InventoryCA$0CA$0-CA$545-CA$964
Other Curr. Assets-CA$25,175CA$718CA$545CA$964
Total Curr. AssetsCA$1,127CA$1,000CA$14,823CA$1,532
Property Plant & Equip (Net)CA$0CA$0CA$0CA$0
GoodwillCA$0CA$0CA$0CA$0
IntangiblesCA$0CA$0CA$0CA$0
Long-Term InvestmentsCA$25,175CA$718CA$545CA$813
Tax AssetsCA$0CA$0CA$0CA$0
Other NC AssetsCA$0CA$0CA$0CA$0
Total NC AssetsCA$25,175CA$718CA$545CA$813
Other AssetsCA$0CA$0CA$0CA$151
Total AssetsCA$26,302CA$26,535CA$39,096CA$37,814
Liabilities––––
PayablesCA$0CA$249CA$348CA$339
Short-Term DebtCA$11,573CA$10,297CA$9,854CA$14,863
Tax PayableCA$0CA$0CA$0CA$0
Deferred RevenueCA$0CA$0CA$0CA$0
Other Curr. Liab.CA$265-CA$10,297CA$9,163-CA$14,863
Total Curr. Liab.CA$11,839CA$249CA$19,365CA$339
LT DebtCA$0CA$0CA$0CA$0
Deferred Rev, NCCA$0CA$0CA$0CA$0
Deferred Tax Liab, NCCA$0CA$0CA$0CA$0
Other NC Liab.CA$780CA$137CA$86CA$209
Total NC Liab.CA$780CA$137CA$86CA$209
Other LiabilitiesCA$12,619CA$0CA$18,670CA$14,733
Cap. LeasesCA$0CA$0CA$0CA$0
Total LiabilitiesCA$12,619CA$10,684CA$19,365CA$15,411
Equity––––
Pref StockCA$0CA$0CA$0CA$0
Common StockCA$13,683CA$15,851CA$19,731CA$22,404
Retained EarningsCA$0CA$0CA$0CA$0
AOCICA$0CA$0CA$0CA$0
Other EquityCA$0CA$15,851CA$19,731CA$22,404
Total EquityCA$13,683CA$15,851CA$19,731CA$22,404
Supplemental Information––––
Minority InterestCA$0CA$0CA$0CA$0
Total Liab. & Tot. EquityCA$26,302CA$26,535CA$39,096CA$37,814
Net DebtCA$10,543CA$10,093CA$9,035CA$13,433